2 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
Follow Corneal Ulcer: new trials by email Literature Review of Corneal Ulcer trials Research Report on Corneal Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis OXERVATE® 0.002% - Neurotrophic Keratitis, Neurotrophic Keratopathy | Phase 4 | Withdrawn | Dompé Farmaceutici S.p.A | 2024-04-26 | 2024-12-02 | |
| Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers Autologous platelet-rich plasma (PRP) eye drops - Cornea Ulcer | Phase 4 | Completed | Alaa Gamal | 14 | 2021-01-01 | 2022-08-25 |
| Steroids for Corneal Ulcers Trial Antibiotics, Topical corticosteroid, Placebo - Corneal Ulcer, Eye Infections, Bacterial | Phase 4 | Completed | Thomas M. Lietman | 500 | 2006-09-01 | 2018-08-01 |
Bacterial Infections (1) · Eye Diseases (1) · Eye Infections, Bacterial (1) · Keratitis (1)
Corneal Diseases (3) · Eye Infections (3) · Infections (3) · Eye Diseases (2) · Keratitis (2) · Bacterial Infections and Mycoses (1)
Adrenal Cortex Hormones (1) · Anti-Bacterial Agents (1) · Moxifloxacin (1) · Ophthalmic Solutions (1) · cenegermin (1)
Alaa Gamal (1) · Dompé Farmaceutici S.p.A (1) · Thomas M. Lietman (1)
Egypt (1) · India (1) · United States (1)
Ahmed Gomaa (1) · Brad Kligman, MD (1) · M. Srinivasan, M.S., O.D. (1) · Mike Zegans, M.D. (1) · Nisha Acharya, M.D., M.S. (1) · Thomas M Lietman, M.D. (1)
PMID 18829631, PMID 21987582, PMID 22159005, PMID 22395880, PMID 22447793, PMID 22959881, PMID 23307105, PMID 23385795, PMID 24315294, PMID 24612976, PMID 24618327, PMID 27631025
U10EY015114 (1)